Literature DB >> 12575888

Preoperative evaluation for postoperative pulmonary complications.

Ahsan M Arozullah1, Michelle V Conde, Valerie A Lawrence.   

Abstract

Preoperative risk assessment for postoperative pulmonary complications is essential when counseling patients about the risks of surgery because of their significant associated morbidity and mortality. There are many patient-related, operation-related, and anesthesia-related risk factors for the development of PPCs. Though many of these risk factors are not modifiable, they can be useful in evaluating preoperative risk, especially when combined into formal risk indices. Preoperative risk assessment enables clinicians to target preoperative testing and perioperative risk reduction strategies to high-risk patients. Reducing PPC risk at the patient level will require a greater understanding of the impact of modifying risk factors through interventional trials. Reducing hospital PPC rates will require future research into the processes of care associated with PPCs through controlled observational and interventional trials.

Entities:  

Mesh:

Year:  2003        PMID: 12575888     DOI: 10.1016/s0025-7125(02)00151-7

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  16 in total

1.  Extensive preoperative testing is not necessary in morbidly obese patients undergoing gastric bypass.

Authors:  Archana Ramaswamy; Rodrigo Gonzalez; C Daniel Smith
Journal:  J Gastrointest Surg       Date:  2004-02       Impact factor: 3.452

2.  The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.

Authors:  Jan Schmitges; Quoc-Dien Trinh; Marco Bianchi; Maxine Sun; Firas Abdollah; Sascha A Ahyai; Claudio Jeldres; Thomas Steuber; Paul Perrotte; Shahrokh F Shariat; Mani Menon; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Journal:  Int Urol Nephrol       Date:  2011-12-13       Impact factor: 2.370

3.  Preoperative evaluation and risk management.

Authors:  David P Parsons
Journal:  Clin Colon Rectal Surg       Date:  2009-02

4.  Capnography monitoring enhances safety of postoperative patient-controlled analgesia.

Authors:  Thomas McCarter; Zakir Shaik; Keith Scarfo; Laura J Thompson
Journal:  Am Health Drug Benefits       Date:  2008-06

Review 5.  Preoperative risk assessment--from routine tests to individualized investigation.

Authors:  Andreas B Böhmer; Frank Wappler; Bernd Zwissler
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

6.  The effect of abdominal support on functional outcomes in patients following major abdominal surgery: a randomized controlled trial.

Authors:  Oren Cheifetz; S Deborah Lucy; Tom J Overend; Jean Crowe
Journal:  Physiother Can       Date:  2010-07-23       Impact factor: 1.037

7.  [Preoperative evaluation of adult patients prior to elective, non-cardiac surgery: joint recommendations of German Society of Anesthesiology and Intensive Care Medicine, German Society of Surgery and German Society of Internal Medicine].

Authors: 
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

Review 8.  [Management of anesthesia in endovascular interventions].

Authors:  T Rössel; R Paul; T Richter; S Ludwig; T Hofmockel; A R Heller; T Koch
Journal:  Anaesthesist       Date:  2016-12       Impact factor: 1.041

Review 9.  Preoperative evaluation of adult patients before elective, noncardiothoracic surgery : Joint recommendation of the German Society of Anesthesiology and Intensive Care Medicine, the German Society of Surgery, and the German Society of Internal Medicine.

Authors:  B Zwissler
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

10.  [Preoperative evaluation of adult patients prior to elective, non-cardiac surgery. Joint recommendations of German Society of Anesthesiology and Intensive Care Medicine, German Society of Surgery and German Society of Internal Medicine].

Authors: 
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.